Pituitary disease and pregnancy.


Journal

Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 03 03 2020
accepted: 07 07 2020
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 11 1 2022
Statut: ppublish

Résumé

Pregnancy results in a significant change in both pituitary gland size and function. Due to this physiological adaptation, the diagnosis and management of pituitary diseases during pregnancy represents a particularly complex challenge. The presence of a functioning pituitary adenoma may be harmful to the health of the mother and fetus, and scientific evidence regarding the safety of drugs normally used to control hormone excess during pregnancy is scarce. In addition, pregnancy may be associated with the risk of the growth of a pre-existing pituitary adenoma. This review focuses on the diagnostic challenges in pregnant women with adenomas secreting prolactin, growth hormone, or adrenocorticotropic hormone. Some evidence-based recommendations for the treatment of these conditions during pregnancy are provided, and algorithms that could help monitor a pituitary adenoma during pregnancy are examined. Mention is also made of how hormone replacement therapy can be optimised in pregnant women with hypopituitarism. Finally, differential diagnosis between Sheehan's syndrome and lymphocytic hypophysitis, two pituitary disorders that may occur during pregnancy or delivery, is discussed.

Identifiants

pubmed: 34167698
pii: S2530-0180(21)00039-1
doi: 10.1016/j.endien.2020.07.002
pii:
doi:

Substances chimiques

Human Growth Hormone 12629-01-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-195

Informations de copyright

Copyright © 2020 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Elena Valassi (E)

Grupo"Enfermedades de Hipófisis" (CIBERER 747), II-B Hospital Sant Pau, Barcelona, Spain; Servicio de Endocrinología, Hospital General de Catalunya, Sant Cugat del Vallès, Spain. Electronic address: EValassi@santpau.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH